ArticleJournal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society
Advancing Knowledge of Acute Cutaneous Graft-Versus-Host Disease Wound Care: A Case Study.
Article in Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute cutaneous graft-versus-host disease (GvHD) is a frequent complication of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). It requires multidisciplinary systemic and topical management. However, no well-established recommendations regarding wound management have been established. This case study describes our experience caring for the wound of a patient with acute myeloid leukemia who developed a grade IV stage 4 acute cutaneous GvHD. CASE: Mr T was a 64-year-old male diagnosed with acute myeloid leukemia with myelodysplasia-related changes. Seventy-five days after receiving an allogeneic human leukocyte antigen-HSCT, he developed wounds on his upper and lower limbs, part of his chest, torso, and sacrum. Four lines of therapy (systemic steroids, tacrolimus together with extracorporeal photopheresis, etanercept, and ruxolitinib) integrated with wound care using advanced dressings of soft silicone layers led to the resolution of his wounds on day 109.
conclusionOur case study provides further evidence for the management of cutaneous GvHD. Further studies are required to assess the effectiveness of silicone layer dressings for managing allogeneic HSCT recipients with cutaneous GvHD on a large scale to provide definitive recommendations for their use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.